BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22069251)

  • 1. Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative.
    Mallone R; Scotto M; Janicki CN; James EA; Fitzgerald-Miller L; Wagner R; Gottlieb P; Thorpe J; Jospe N; Durinovic-Bellò I; Boitard C; Lou O; Dayan CM; Wong FS;
    Diabetes Metab Res Rev; 2011 Nov; 27(8):720-6. PubMed ID: 22069251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunology of Diabetes Society T-Cell Workshop: HLA class II tetramer-directed epitope validation initiative.
    James EA; Mallone R; Schloot NC; Gagnerault MC; Thorpe J; Fitzgerald-Miller L; Reichow J; Wagner R; Pham MN; Jospe N; Lou O; Gottlieb PA; Brooks-Worrell BM; Durinovic-Belló I;
    Diabetes Metab Res Rev; 2011 Nov; 27(8):727-36. PubMed ID: 22069252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
    Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R
    Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers.
    Unger WW; Velthuis J; Abreu JR; Laban S; Quinten E; Kester MG; Reker-Hadrup S; Bakker AH; Duinkerken G; Mulder A; Franken KL; Hilbrands R; Keymeulen B; Peakman M; Ossendorp F; Drijfhout JW; Schumacher TN; Roep BO
    J Autoimmun; 2011 Nov; 37(3):151-9. PubMed ID: 21636247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class I epitope discovery in type 1 diabetes.
    van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R
    Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes.
    Ouyang Q; Standifer NE; Qin H; Gottlieb P; Verchere CB; Nepom GT; Tan R; Panagiotopoulos C
    Diabetes; 2006 Nov; 55(11):3068-74. PubMed ID: 17065344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preproinsulin-specific CD8+ T cells secrete IFNgamma in human type 1 diabetes.
    Rathmann S; Rajasalu T; Rosinger S; Schlosser M; Eiermann T; Boehm BO; Durinovic-Belló I
    Ann N Y Acad Sci; 2004 Dec; 1037():22-5. PubMed ID: 15699489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients.
    Scheibenbogen C; Lee KH; Mayer S; Stevanovic S; Moebius U; Herr W; Rammensee HG; Keilholz U
    Clin Cancer Res; 1997 Feb; 3(2):221-6. PubMed ID: 9815676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes.
    Mallone R; Martinuzzi E; Blancou P; Novelli G; Afonso G; Dolz M; Bruno G; Chaillous L; Chatenoud L; Bach JM; van Endert P
    Diabetes; 2007 Mar; 56(3):613-21. PubMed ID: 17327428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
    Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
    BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity.
    Abreu JR; Martina S; Verrijn Stuart AA; Fillié YE; Franken KL; Drijfhout JW; Roep BO
    Clin Exp Immunol; 2012 Oct; 170(1):57-65. PubMed ID: 22943201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule.
    van Lummel M; van Veelen PA; de Ru AH; Pool J; Nikolic T; Laban S; Joosten A; Drijfhout JW; Gómez-Touriño I; Arif S; Aanstoot HJ; Peakman M; Roep BO
    Diabetes; 2016 Mar; 65(3):732-41. PubMed ID: 26718497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients.
    Blancou P; Mallone R; Martinuzzi E; Sévère S; Pogu S; Novelli G; Bruno G; Charbonnel B; Dolz M; Chaillous L; van Endert P; Bach JM
    J Immunol; 2007 Jun; 178(11):7458-66. PubMed ID: 17513797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cells.
    Kronenberg D; Knight RR; Estorninho M; Ellis RJ; Kester MG; de Ru A; Eichmann M; Huang GC; Powrie J; Dayan CM; Skowera A; van Veelen PA; Peakman M
    Diabetes; 2012 Jul; 61(7):1752-9. PubMed ID: 22522618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope.
    Ohnishi M; Sakurai T; Heike Y; Yamazaki R; Kanda Y; Takaue Y; Mizoguchi H; Kawakami Y
    Br J Haematol; 2005 Nov; 131(4):472-9. PubMed ID: 16281937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of T cell epitopes by the use of rapidly generated mRNA fragments.
    Britten CM; Meyer RG; Graf C; Huber C; Wölfel T
    J Immunol Methods; 2005 Apr; 299(1-2):165-75. PubMed ID: 15914199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
    van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
    J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.
    Pinkse GG; Tysma OH; Bergen CA; Kester MG; Ossendorp F; van Veelen PA; Keymeulen B; Pipeleers D; Drijfhout JW; Roep BO
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18425-30. PubMed ID: 16339897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.
    Endl J; Otto H; Jung G; Dreisbusch B; Donie F; Stahl P; Elbracht R; Schmitz G; Meinl E; Hummel M; Ziegler AG; Wank R; Schendel DJ
    J Clin Invest; 1997 May; 99(10):2405-15. PubMed ID: 9153283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes.
    Sarikonda G; Pettus J; Phatak S; Sachithanantham S; Miller JF; Wesley JD; Cadag E; Chae J; Ganesan L; Mallios R; Edelman S; Peters B; von Herrath M
    J Autoimmun; 2014 May; 50():77-82. PubMed ID: 24387802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.